Profile
BDXB ISRG BDXA BDX RMD ALC
Company Name Becton, Dickinson and Company Intuitive Surgical, Inc. Becton, Dickinson and Company Becton, Dickinson and Company ResMed Inc. Alcon Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Medical - Instruments & Supplies Medical - Instruments & Supplies Medical - Instruments & Supplies Medical - Instruments & Supplies Medical - Instruments & Supplies Medical - Instruments & Supplies
Market Cap $13.69B $167.60B $55.91B $54.60B $40.88B $39.47B
Employees 77.00K 15.64K 0.00K 70.00K 9.98K 25.60K
CEO Thomas E. Polen Jr. Gary S. Guthart - Thomas E. Polen Jr. Michael J. Farrell BE, MBA, SM David J. Endicott
Ratings
BDXB ISRG BDXA BDX RMD ALC
Quant Rating Score 4 3 5 3 4 3
Quant Rating Buy Neutral Strong Buy Neutral Buy Neutral
Trading
BDXB ISRG BDXA BDX RMD ALC
Last Close $48.16 $449.68 $59.24 $186.84 $270.14 $78.29
High 52 $48.16 $610.45 $59.24 $249.08 $293.73 $100.07
Low 52 $48.16 $441.23 $59.24 $165.15 $204.58 $77.87
Price vs. 52 Week High 0 % -26.34 % 0 % -24.99 % -8.03 % -21.76 %
Price vs. 52 Week Low 0 % 1.92 % 0 % 13.13 % 32.05 % 0.54 %
Total Return
BDXB ISRG BDXA BDX RMD ALC
1 Month Return 0 % -6.83 % 0 % -4.65 % -6.32 % -9.47 %
3 Month Return 0 % -12.2 % 0 % 8.5 % 8.34 % -9.18 %
6 Month Return 0 % -5.65 % 0 % -16.14 % 22.95 % -9.81 %
9 Month Return 0 % -16.65 % 0 % -17.15 % 13.26 % -6.92 %
YTD Return 0 % -13.85 % 0 % -17.64 % 18.12 % -7.77 %
1 Year Return 0 % -8.2 % 0 % -20.22 % 8.52 % -20.52 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
BDXB ISRG BDXA BDX RMD ALC
Dividend Yield Percentage (TTM) 2.23 % - 2.13 % 2.18 % 0.78 % 0.42 %
Dividend Paid and Capex Coverage Ration (TTM) 1.73 % 3.4 % 1.73 % 1.73 % 4.34 % 3.26 %
Dividend Per Share (TTM) 4.16 % - 4.07 % 4.16 % 2.19 % 0.33 %
Payout Ratio (TTM) 73.1 % - 73.1 % 73.1 % 22.19 % 15.71 %
Profitability
BDXB ISRG BDXA BDX RMD ALC
Gross Profit Margin TTM 45.08 % 66.65 % 45.08 % 45.08 % 59.36 % 55.13 %
Return on Assets TTM 2.93 % 12.93 % 2.93 % 2.93 % 17.14 % 3.42 %
Return on Equity TTM 6.31 % 15.57 % 6.31 % 6.31 % 25.51 % 4.93 %
Return on Capital Employed TTM 5.78 % 14.26 % 5.78 % 5.78 % 23.58 % 4.98 %
Net Income Per EBT TTM 83.91 % 87.46 % 83.91 % 83.91 % 83.5 % 85.57 %
EBT Per Ebit TTM 70.86 % 113.2 % 70.86 % 70.86 % 99.42 % 86.96 %
EBIT Per Revenue TTM 12.63 % 28.8 % 12.63 % 12.63 % 32.79 % 14.38 %
Cash Flow To Debt Ratio TTM 16.82 % - 16.82 % 16.82 % 198.52 % 39.27 %
Receivables Turnover TTM 7.27 6.56 7.27 7.27 5.48 4.98
Payables Turnover TTM 1.85 11.43 - 1.85 7.52 5.03
Inventory Turnover TTM 2.97 1.83 2.97 2.97 2.25 1.88
Fixed Asset Turnover TTM 313.67 % 183.44 % 313.67 % 313.67 % 716.47 % 197.54 %
Asset Turnover TTM 38.95 % 45.35 % 38.95 % 38.95 % 62.96 % 31.94 %
Operating Cash Flow Per Share TTM 11.3 7.88 11.3 11.3 11.96 4.16
Free Cash Flow Per Share TTM 8.85 5.56 8.85 8.85 11.32 3.23
Cash Per Share TTM 262.85 % 1485.77 % 262.85 % 262.85 % 834.65 % 284.33 %
Operating Cash Flow Sales Ratio TTM 15.22 % 30.9 % 15.22 % 15.22 % 34.04 % 20.57 %
Free Cash Flow Operating Cash Flow Ratio TTM 78.37 % 70.57 % 78.37 % 78.37 % 94.7 % 77.51 %
Cash Flow Coverage Ratios TTM 16.82 % - 16.82 % 16.82 % 198.52 % 39.27 %
Price To Free Cash Flows Ratio TTM 21 84.04 21.5 21.41 24.64 24.7
Price To Operating Cash Flows Ratio TTM 16.54 59.31 16.93 16.86 23.35 19.17
Price Cash Flow Ratio TTM 16.54 59.31 16.93 16.86 23.35 19.17
Income Statement (TTM)
BDXB ISRG BDXA BDX RMD ALC
Revenue $20.18B $8.35B $20.18B $20.18B $5.15B $9.91B
Gross Profit $9.13B $5.63B $9.13B $9.13B $3.05B $5.51B
Gross Profit Ratio 45.22% 67.46% 45.22% 45.22% 59.36% 55.61%
EBITDA $4.82B $2.81B $4.82B $4.82B $1.91B $2.68B
Net Income $1.71B $2.32B $1.71B $1.71B $1.4B $1.02B
EPS Diluted 5.86 6.42 5.86 5.86 9.51 2.05
Balance Sheet (MRQ)
BDXB ISRG BDXA BDX RMD ALC
Long Term Debt $18.61B $0.11B $18.61B $18.61B $0.81B $4.97B
Total Liabilities $31.4B $2.31B $31.4B $31.4B $2.21B $8.79B
Total Equity $25.89B $16.53B $25.89B $25.89B $5.97B $21.55B
Total Investments $0.45B $7.05B $0.45B $0.45B $0.1B $0.91B
Total Debt $20.92B $0.15B $20.92B $20.92B $0.88B $5.14B
Total Assets $57.29B $18.84B $57.29B $57.29B $8.17B $30.35B
Cash Flow Statement (TTM)
BDXB ISRG BDXA BDX RMD ALC
Net Income $1.71B $2.34B $1.71B $1.71B $1.4B $1.02B
Inventory $0.1B $-0.83B $0.1B $0.1B $-0.08B $-0.05B
Dividends Paid $-1.1B $0B $-1.1B $-1.1B $-0.31B $-0.13B
Operating Cash Flow $3.8B $2.42B $3.8B $3.8B $1.75B $2.08B
Capital Expenditure $-0.73B $-1.11B $-0.73B $-0.73B $-0.09B $-0.67B
Related Stocks
Ticker Name Price
AKYA Akoya Biosciences, Inc. 1.29
ALC Alcon Inc. 78.29
ANGO AngioDynamics, Inc. 10.65
APR Apria, Inc. 37.5
ATR AptarGroup, Inc. 135.23
ATRC AtriCure, Inc. 35.07
ATRI Atrion Corporation 459.92
ATRS Antares Pharma, Inc. 5.59
AVGR Avinger, Inc. 0.474
AZTA Azenta, Inc. 29.66
BAX Baxter International Inc. 23.99
BDX Becton, Dickinson and Company 186.84
BDXA Becton, Dickinson and Company 59.24
BLCO Bausch + Lomb Corporation 15.19
BLFS BioLife Solutions, Inc. 25.51
COO The Cooper Companies, Inc. 66.68
DXR Daxor Corporation 11.66
EKSO Ekso Bionics Holdings, Inc. 3.83
FEMY Femasys Inc. 0.3921
GCTK GlucoTrack, Inc. 10.59
ETFs With Exposure to BDXB
Ticker ETF Name Weight Percentage Price
FCVT First Trust SSI Strategic Convertible Securities ETF 0.39 41.745
HSUN Hartford Sustainable Income ETF 0.134074 33.534
QPFF American Century Quality Preferred ETF 0.68 35.701
Unlock